Show simple item record

dc.contributor.authorKotteas, E. A.en
dc.contributor.authorPavlidis, Nicholasen
dc.creatorKotteas, E. A.en
dc.creatorPavlidis, Nicholasen
dc.date.accessioned2018-06-22T09:53:50Z
dc.date.available2018-06-22T09:53:50Z
dc.date.issued2015
dc.identifier.urihttps://gnosis.library.ucy.ac.cy/handle/7/42050
dc.description.abstractMerkel cell nodal carcinoma of unknown primary (MCCUP) is a rare neuroendocrine tumour with distinct clinical and biological behaviour. We conducted a review of retrospective data extracted from 90 patients focusing on the management and outcome of this disease. We also compared life expectancy of these patients with the outcome of patients with known Merkel primaries and with neuroendocrine cancers of unidentifiable primary. There is a limited body of data for this type of malignancy, however, patients with Merkel cell nodal carcinoma of unknown primary site, seem to have better survival when treated aggressively than patients with cutaneous Merkel tumours of the same stage and equal survival with patients with low-grade neuroendocrine tumour of unknown origin. The lack of prospective trials, and the inadequate data, hamper the management of these tumours. Establishment of treatment guidelines is urgently needed. © 2014 Elsevier Ireland Ltd.en
dc.language.isoengen
dc.sourceCritical reviews in oncology/hematologyen
dc.subjectReviewen
dc.subjectCisplatinen
dc.subjectEtoposideen
dc.subjectHumanen
dc.subjectNeoplasmsen
dc.subjectHumansen
dc.subjectCancer survivalen
dc.subjectCarboplatinen
dc.subjectComputer assisted tomographyen
dc.subjectPlatinum derivativeen
dc.subjectPrognosisen
dc.subjectRetrospective studyen
dc.subjectCancer stagingen
dc.subjectOverall survivalen
dc.subjectOutcome assessmenten
dc.subjectCarcinomaen
dc.subjectSkin neoplasmsen
dc.subjectMortalityen
dc.subjectMeta analysisen
dc.subjectSex differenceen
dc.subjectImmunohistochemistryen
dc.subjectProtein expressionen
dc.subjectCancer gradingen
dc.subjectHistopathologyen
dc.subjectLymph node dissectionen
dc.subjectLymph node metastasisen
dc.subjectSurvival timeen
dc.subjectHigh risk populationen
dc.subjectCancer therapyen
dc.subjectTreatment responseen
dc.subjectCancer of unknown primary siteen
dc.subjectUnknown primaryen
dc.subjectCytokeratin 20en
dc.subjectCytokeratin 7en
dc.subjectUnknown primaryen
dc.subjectNeuroendocrine tumoren
dc.subjectCd56 antigenen
dc.subjectComputer assisted emission tomographyen
dc.subjectStem cell factor receptoren
dc.subjectNeuroendocrine tumorsen
dc.subjectAdjuvant chemoradiotherapyen
dc.subjectCancer morphologyen
dc.subjectChromogranin aen
dc.subjectDisease managementen
dc.subjectLife expectancyen
dc.subjectLocal excisionen
dc.subjectMerkel carcinomaen
dc.subjectMerkel cellen
dc.subjectMerkel cell nodal carcinoma of unknown primaryen
dc.subjectMerkel cell tumoren
dc.subjectNeurofilament proteinen
dc.subjectPatient outcome assessmenten
dc.subjectRecurrence free survivalen
dc.subjectSecondaryen
dc.titleNeuroendocrine Merkel cell nodal carcinoma of unknown primary site: Management and outcomes of a rare entityen
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.critrevonc.2014.12.005
dc.description.volume94
dc.description.issue1
dc.description.startingpage116
dc.description.endingpage121
dc.author.facultyΙατρική Σχολή / Medical School
dc.author.departmentΙατρική Σχολή / Medical School
dc.type.uhtypeArticleen
dc.contributor.orcidPavlidis, Nicholas [0000-0002-2195-9961]
dc.gnosis.orcid0000-0002-2195-9961


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record